Literature DB >> 12521301

Gene expression profile analysis in human hepatocellular carcinoma by cDNA microarray.

Eun Jung Chung1, Young Kwan Sung, Mohammad Farooq, Younghee Kim, Sanguk Im, Won Young Tak, Yoon Jin Hwang, Yang Il Kim, Hyung Soo Han, Jung-Chul Kim, Moon Kyu Kim.   

Abstract

We performed gene expression profiling of normal and hepatocellular carcinoma (HCC) liver tissues using a high-density microarray that contained 3,063 human cDNA. The results of a microarray hybridization experiment from eight different HCC tissues were analyzed and classified by the Cluster program. Among these differentially-expressed genes, the galectin-3, serine/threonine kinase SGK, translation factor eIF-4A, -4B, -3, fibroblast growth factor receptor, and ribosomal protein L35A were up-regulated; the mRNAs of Nip3, decorin, and the insulin-like growth factor binding protein-3 were down-regulated in HCC. The differential expression of these genes was further confirmed by an RT-PCR analysis. In addition, our data suggest that the gene expression profile of HCC varies according to the histological types.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12521301

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  29 in total

Review 1.  Genetics of hepatocellular carcinoma.

Authors:  Andreas Teufel; Frank Staib; Stephan Kanzler; Arndt Weinmann; Henning Schulze-Bergkamen; Peter-R Galle
Journal:  World J Gastroenterol       Date:  2007-04-28       Impact factor: 5.742

Review 2.  Proteoglycans in liver cancer.

Authors:  Kornélia Baghy; Péter Tátrai; Eszter Regős; Ilona Kovalszky
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 3.  mTOR signaling in tumorigenesis.

Authors:  Kai Xu; Pengda Liu; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2014-11-01

4.  Molecular genetics of hepatocellular neoplasia.

Authors:  Shilpa Jain; Shashideep Singhal; Peng Lee; Ruliang Xu
Journal:  Am J Transl Res       Date:  2010-01-23       Impact factor: 4.060

5.  Decreased apoptosis in advanced-stage/high-grade hepatocellular carcinoma complicating chronic hepatitis C is mediated through the downregulation of p21 ras.

Authors:  Nahed Baddour; Ebtehal Farrag; Ahmed Zeid; Essam Bedewy; Yousry Taher
Journal:  Chin J Cancer Res       Date:  2013-06       Impact factor: 5.087

6.  Decorin interferes with platelet-derived growth factor receptor signaling in experimental hepatocarcinogenesis.

Authors:  Kornélia Baghy; Zsolt Horváth; Eszter Regős; Katalin Kiss; Zsuzsa Schaff; Renato V Iozzo; Ilona Kovalszky
Journal:  FEBS J       Date:  2013-03-25       Impact factor: 5.542

7.  Defining a role for Sonic hedgehog pathway activation in desmoplastic medulloblastoma by identifying GLI1 target genes.

Authors:  Joon Won Yoon; Richard Gilbertson; Stephen Iannaccone; Philip Iannaccone; David Walterhouse
Journal:  Int J Cancer       Date:  2009-01-01       Impact factor: 7.396

8.  Sgk1 activates MDM2-dependent p53 degradation and affects cell proliferation, survival, and differentiation.

Authors:  Rosario Amato; Lucia D'Antona; Giovanni Porciatti; Valter Agosti; Miranda Menniti; Cinzia Rinaldo; Nicola Costa; Emanuele Bellacchio; Stefano Mattarocci; Giorgio Fuiano; Silvia Soddu; Marco G Paggi; Florian Lang; Nicola Perrotti
Journal:  J Mol Med (Berl)       Date:  2009-09-11       Impact factor: 4.599

9.  Proteomic analysis of HCV cirrhosis and HCV-induced HCC: identifying biomarkers for monitoring HCV-cirrhotic patients awaiting liver transplantation.

Authors:  Valeria R Mas; Daniel G Maluf; Kellie J Archer; Kenneth Yanek; Karen Bornstein; Robert A Fisher
Journal:  Transplantation       Date:  2009-01-15       Impact factor: 4.939

Review 10.  CYP3A4 Gene Is a Novel Biomarker for Predicting a Poor Prognosis in Hepatocellular Carcinoma.

Authors:  Ryo Ashida; Yukiyasu Okamura; Keiichi Ohshima; Yuko Kakuda; Katsuhiko Uesaka; Teiichi Sugiura; Takaaki Ito; Yusuke Yamamoto; Takashi Sugino; Kenichi Urakami; Masatoshi Kusuhara; Ken Yamaguchi
Journal:  Cancer Genomics Proteomics       Date:  2017 Nov-Dec       Impact factor: 4.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.